May 21, 2024
PHOENIX — The use of radiotherapy has been steadily increasing by dermatologists, according to new findings from a study analyzing trends in Medicare claims from 2016 […]
May 20, 2024
On this page As announced in the Federal Register notice published on October 20, 2022, FDA is conducting an Advancing Real-World Evidence (RWE) Program, which seeks […]
May 20, 2024
SAN DIEGO — Patients with idiopathic pulmonary fibrosis (IPF) had significant improvements in lung function and reversal of lung fibrosis measures after 12 weeks of therapy […]
May 20, 2024
People with HIV who wish to breastfeed their infants should have sustained viral suppression, with a viral load below 50 copies per mL, to have the […]
May 20, 2024
WASHINGTON, DC — The selective interleukin (IL)–23p29 monoclonal antibody mirikizumab demonstrated safety and efficacy in people with moderate to severe Crohn’s disease compared with placebo up […]
May 20, 2024
More Than an Estimated 6 Million People Aged 12 or Older Have Opioid Use Disorder Many primary care providers likely already provide medical care to people […]
May 20, 2024
Image By: Hilary Marston, MD, MPH, Chief Medical Officer and Kevin Bugin, PhD, Deputy Director of Operations in the Office of New Drugs, Center for Drug […]
May 20, 2024
On this page Screening and Diagnosing Opioid Use Disorder in Primary Care Settings An estimated 6.1 million people over the age of 12 have an opioid […]
May 20, 2024
What is Prescribe with Confidence About? Prescribe with Confidence is an educational campaign to help providers recognize and treat opioid use disorder (OUD). Opioid use disorder […]